by Cynthia McCormick Hibbert, Northeastern University Credit: Pixabay/CC0 Public DomainHuman safety trials of a novel antibiotic treatment for Lyme disease developed by Northeastern professor Kim Lewis are scheduled to start this spring in Australia, with results anticipated by fall. So far the therapeutic agent, an antibiotic known as hygromycin A, has not been toxic in animals...
by University of Alabama at Birmingham Credit: Pixabay/CC0 Public Domain A fecal microbial transplant—giving a recipient fecal matter from a donor to change the recipient’s gut microbial community in the colon—has been a successful last resort therapy for people with recurrent Clostridium difficile infection after multiple rounds of suppressive antibiotics have eliminated the recipient microbial...
by Harvard Pilgrim Health Care Institute A new study led by researchers at the Harvard Pilgrim Health Care Institute developed an algorithm that could greatly reduce use of broad-spectrum antibiotics in outpatient settings, a step toward reducing antibiotic resistance. The findings will be published online November 4, 2020 in Science Translational Medicine. As discussed by the authors, antibiotic...
Vitamin D has been found to speed up the clearance of tuberculosis (TB) bacteria from the lungs of people with multi-drug resistant TB, according to a study of 1,850 patients receiving antibiotic treatment, led by Queen Mary University of London. Lead researcher Professor Adrian Martineau from Queen Mary University of London said: “Multi-drug resistant TB...
The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use...
